# Urokinase

## UROKINASE 60，000IU

##### 

| 藥品代碼   | IUROK                                                                                                                                                                                                                                                         |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Acute coronary embolism， clearance of occluded catheters & shunts， acute pulmonary embolism， peripheral arterial or venous thromboembolism.                                                                                                                |
| 用法用量   | 60000-240000 IU on the first day， then decrease the dose day by day for about 7 days.                                                                                                                                                                        |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                  |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                  |
| 禁忌       | Intracranial hemorrhage， hemoptysis， difficulty in hemostatic management; undergone intracranial or spinal surgery or with such injury (in the last 2 months); aneurysm; serious disturbance of consciousness.                                              |
| 副作用     | Bleeding tendency. Fever， chills， headache & malaise may occur. Rarely， shock， sweating， disturbed pulse & dyspnea; rash， urticaria;nausea; vomiting & anorexia; abnormal liver function test; hematuria. Hematologic: Decreased hematocrit level (37%) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                        |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                           |

